Cited by 234Asthma and respiratory diseasesChronic Obstructive Pulmonary Disease (COPD) ResearchOccupational exposure and asthma

Co‐morbidities in severe asthma: C linical impact and management

Porsbjerg, Celeste, Menzies‐Gow, Andrew·2017·Respirology

Abstract

Patients with severe asthma represent a minority of the total asthma population, but carry a majority of the morbidity and healthcare costs. Achieving better asthma control in this group of patients is therefore of key importance. Systematic assessment of patients with possible severe asthma to identify treatment barriers and triggers of asthma symptoms, including co-morbidities, improves asthma control and reduces healthcare costs and is recommended by international guidelines on management of severe asthma. This review provides the clinician with an overview of the prevalence and clinical impact of the most common co-morbidities in severe asthma, including chronic rhinosinusitis, nasal polyposis, allergic rhinitis, dysfunctional breathing, vocal cord dysfunction, anxiety and depression, obesity, obstructive sleep apnoea syndrome (OSAS), gastroesophageal reflux disease (GERD), bronchiectasis, allergic bronchopulmonary aspergillosis (ABPA) and eosinophilic granulomatous with polyangiitis (EGPA). Furthermore, the review offers a summary of recommended diagnostic and management approaches for each co-morbidity. Finally, the review links co-morbid conditions to specific phenotypes of severe asthma, in order to guide the clinician on which co-morbidities to look for in specific patients.

Integrity signals

Registry

Crossref · 10.1111/resp.13026

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatment of comorbid disorders co-occurring with asthma may improve asthma control, although there is a paucity of evidence to support this from well-designed randomized intervention trials.

    “Treatment of these disorders co-occurring with asthma may improve asthma control (65), although there is a paucity of evidence to support this from well-designed randomized intervention trials (67).”

    From Epidemiology of Asthma in Children and Adults (2019) · cites this paper as [67]

Cites

Flagged first, then by citations

1 of the 125 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Porsbjerg, C., & Menzies‐Gow, A.
Affiliations
  • Bispebjerg Hospital (DK)
  • Royal Brompton and Harefield NHS Foundation Trust London UK
Corresponding author
Porsbjerg, Celeste
Venue
Respirology
Publisher
Wiley
Published
2017-03-22
Volume
22
Issue
4
Pages
651-661
ISSN
  • 1323-7799 (ISSN-L)
  • 1440-1843
OpenAlex
W2601652410
Cited by
233
References
125
Citations by year
2026: 14 · 2025: 19 · 2024: 27 · 2023: 32 · 2022: 24 · 2021: 25 · 2020: 32 · 2019: 25 · 2018: 23 · 2017: 12
FWCI
3.09
Type
journal article
Language
en
Open access
closed
Locations
  • Respirology (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
Keywords
severe asthma, comorbidities, asthma phenotypes, chronic rhinosinusitis, nasal polyps, allergic rhinitis, dysfunctional breathing, vocal cord dysfunction, anxiety and depression, obesity, obstructive sleep apnea, gastroesophageal reflux disease, bronchiectasis, allergic bronchopulmonary aspergillosis, eosinophilic granulomatosis with polyangiitis, asthma control, health care costs
MeSH terms
Aspergillosis, Allergic Bronchopulmonary, Asthma, Bronchiectasis, Chronic Disease, Gastroesophageal Reflux, Humans, Global Health, Comorbidity, Disease Management, Sleep Apnea, Obstructive, Rhinitis, Allergic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review